» Articles » PMID: 26330639

Postmenopausal Syndrome

Overview
Specialty Psychiatry
Date 2015 Sep 3
PMID 26330639
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

Menopause is one of the most significant events in a woman's life and brings in a number of physiological changes that affect the life of a woman permanently. There have been a lot of speculations about the symptoms that appear before, during and after the onset of menopause. These symptoms constitute the postmenopausal syndrome; they are impairing to a great extent to the woman and management of these symptoms has become an important field of research lately. This chapter attempts to understand these symptoms, the underlying pathophysiology and the management options available.

Citing Articles

Estrogen Treatment Lowers the Risk of Complications in Menopausal Women with Mild Burn Injury.

Song J, Golovko G, Botnar K, El Ayadi A, Vincent K, Wolf S Medicina (Kaunas). 2025; 61(2).

PMID: 40005417 PMC: 11857297. DOI: 10.3390/medicina61020300.


Translation and Validation of the Tamil Version of the Menopause Rating Scale.

Ekanayake C, Ranasinghe S, Pathmeswaran A, Muhunthan K J Midlife Health. 2025; 15(4):280-285.

PMID: 39959735 PMC: 11824926. DOI: 10.4103/jmh.jmh_174_24.


Women's Menopausal Experiences in the UK: A Systemic Literature Review of Qualitative Studies.

Anto A, Basu A, Selim R, Eisingerich A Health Expect. 2025; 28(1):e70167.

PMID: 39888228 PMC: 11780249. DOI: 10.1111/hex.70167.


Lactococcus lactis and Bifidobacterium bifidum alleviate postmenopausal symptoms by suppressing NF-κB signaling and microbiota dysbiosis.

Shin Y, Ma X, Joo M, Baek J, Kim D Sci Rep. 2024; 14(1):31675.

PMID: 39738244 PMC: 11685947. DOI: 10.1038/s41598-024-81500-0.


A look into the cancer continuum for the development of a physical activity intervention: qualitative investigation of the physical activity experiences and preferences of female cancer survivors.

Lavoie H, Scotti K, Christou D, Jake-Schoffman D Support Care Cancer. 2024; 32(11):759.

PMID: 39477901 DOI: 10.1007/s00520-024-08955-9.


References
1.
Bromberger J, Assmann S, Avis N, Schocken M, Kravitz H, Cordal A . Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am J Epidemiol. 2003; 158(4):347-56. DOI: 10.1093/aje/kwg155. View

2.
Dennerstein L, Dudley E, Hopper J, Guthrie J, Burger H . A prospective population-based study of menopausal symptoms. Obstet Gynecol. 2000; 96(3):351-8. DOI: 10.1016/s0029-7844(00)00930-3. View

3.
Harris S, Watts N, Genant H, McKeever C, Hangartner T, Keller M . Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA. 1999; 282(14):1344-52. DOI: 10.1001/jama.282.14.1344. View

4.
Shumaker S, Legault C, Rapp S, Thal L, Wallace R, Ockene J . Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003; 289(20):2651-62. DOI: 10.1001/jama.289.20.2651. View

5.
Krystal A . Depression and insomnia in women. Clin Cornerstone. 2004; 6 Suppl 1B:S19-28. DOI: 10.1016/s1098-3597(04)80022-x. View